Oct 28HHS draft policy lets licensed pharmacies compound six peptides, including BPC-157. What changed and what did not.
Skip to content
PeptideAgent

Compounding pharmacies in Montana

By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed.  Last verified

The Montana Board of Pharmacy (Department of Labor and Industry, Business Standards Division) regulates compounding pharmacies in Montana. Compounded GLP-1 limited. How to check a pharmacy's license, plus listings with their verification status.

Montana at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async allowed
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Compounding pharmacies serving Montana

No verified compounding pharmacies serving Montana are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Who regulates compounding pharmacies in Montana

The Montana Board of Pharmacy licenses pharmacies under MCA Title 37, chapter 7, and adopts rules in ARM Title 24, chapter 174. Part 7 of chapter 7 (MCA 37-7-701 and following) requires every out-of-state mail order pharmacy that ships prescriptions to Montana residents to register with the Board, submit a good-standing certificate from its home-state licensing authority, disclose ownership and officers, and identify the home-state pharmacist in charge of dispensing to Montana (MCA 37-7-703; ARM 24.174.1001 and 24.174.1003). Montana has no state bulks list; peptide eligibility follows the federal 503A framework. Montana's sterile compounding standards are in ARM 24.174.841 (sterile products), in subchapter 8 of the Board's rules (pharmacies), which requires compounding pharmacies to keep policies and procedures that comply with the spirit of USP chapters 795 and 797. The Board has proposed amending that rule and adopting new rules on nonsterile compounding, hazardous drug handling, and outsourcing facilities in MAR Notice No. 2026-131 (public hearing August 14, 2026); this record treats those changes as proposals until the Board adopts them. [1] [2] [3] [4] [5] [7]

Compounded GLP-1 access in Montana

Rural Montana patients often rely on mail order; any out-of-state pharmacy mailing compounded GLP-1s into Montana must be registered as an out-of-state mail order pharmacy under MCA 37-7-703. [2] [10]

Research use only sellers in Montana

The Montana Food, Drug, and Cosmetic Act (MCA Title 50, chapter 31) prohibits selling adulterated or misbranded drugs, and MCA Title 37, chapter 7 restricts dispensing of prescription drugs to licensed pharmacies. [1] [2] [6] [11]

How to check a compounding pharmacy in Montana

  1. Search the Montana Board of Pharmacy (Department of Labor and Industry, Business Standards Division) license lookup for the pharmacy by name. A pharmacy based elsewhere needs whatever license or registration Montana requires before it ships to you. [1] [2] [3] [4] [5] [7]
  2. Ask whether it operates as a 503A pharmacy or a 503B outsourcing facility, and confirm a 503B claim against FDA's outsourcing facility information (see the verification checklist).
  3. Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Montana. [1] [2] [6] [11]

Common questions in Montana

Can an out-of-state pharmacy mail compounded peptides to me in Montana?

Only if it is registered with the Montana Board of Pharmacy as an out-of-state mail order pharmacy under MCA 37-7-703, which requires a home-state good-standing certificate and a named pharmacist in charge of Montana dispensing. [2] [3]

Can a Montana pharmacy compound BPC-157?

Only under a draft federal policy, and only within strict limits. On October 28, 2026 HHS released a draft enforcement discretion policy saying it will not take enforcement action against a state-licensed pharmacy that compounds BPC-157 as a single-ingredient product by an allowed route, on a patient-specific prescription, from an FDA-registered manufacturer's substance with a tested certificate of analysis, with serious adverse events reported to FDA. BPC-157 is still not FDA approved or on the 503A bulks list, the policy is not binding and HHS may revisit it, and blends such as Wolverine are not covered. FDA's drug center recommended against listing BPC-157; the advisory committee voted in favor (HHS policy, Appendix B). State law still applies: Montana has no state bulks list; peptide eligibility follows the federal 503A framework. [7] [8] [9] [12] [13]

All peptide legal questions for Montana

Sources

  1. [1]Montana Board of Pharmacy
  2. [2]MCA 37-7-703, Out-of-state mail order pharmacy registration requirements
  3. [3]ARM 24.174.1001, Registration of out-of-state mail service pharmacies
  4. [4]ARM 24.174.841, Sterile products
  5. [5]Montana Board of Pharmacy, MAR Notice No. 2026-131, proposed amendment of ARM 24.174.841 and adoption of compounding rules
  6. [6]MCA Title 50, chapter 31, Food, drugs, and cosmetics
  7. [7]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  8. [8]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (503A and 503B category lists)FDA
  9. [9]FDA: Pharmacy Compounding Advisory CommitteeFDA
  10. [10]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA